These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6299534)

  • 1. Role of suppressor cells in feline leukemia virus-associated immunosuppression.
    Langweiler M; Cockerell GL; deNoronha F
    Cancer Res; 1983 May; 43(5):1957-60. PubMed ID: 6299534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
    Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the short-lived suppressive function of peripheral leukocytes in feline retrovirus-infected cats.
    Stiff MI; Olsen RG
    J Clin Lab Immunol; 1982 Feb; 7(2):133-8. PubMed ID: 6279852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines.
    Dunlap JE; Nichols WS; Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1979 Mar; 39(3):956-8. PubMed ID: 218726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of normal lymphocyte mitogenic reactivity by serum from feline leukemia virus-infected cats.
    Cockerell GL; Hoover EA
    Cancer Res; 1977 Nov; 37(11):3985-9. PubMed ID: 198125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus.
    Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1977 Dec; 37(12):4532-3. PubMed ID: 200353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of retrovirus suppression of human T cell proliferation in vitro.
    Copelan EA; Rinehart JJ; Lewis M; Mathes L; Olsen R; Sagone A
    J Immunol; 1983 Oct; 131(4):2017-20. PubMed ID: 6311904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus.
    Hebebrand LC; Olsen RG; Mathes LE; Nichols WS
    Cancer Res; 1979 Feb; 39(2 Pt 1):443-7. PubMed ID: 216488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP
    Nature; 1978 Aug; 274(5672):687-9. PubMed ID: 209338
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection and evaluation of feline oncornavirus-induced cell surface antigen(s) shed from cells in vitro.
    Wolff LH; Mathes LE; Schaller JP; Hoover EA; Olsen RG
    Cancer Res; 1977 Nov; 37(11):4134-7. PubMed ID: 198129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 suppression in cats naturally infected with feline leukemia virus.
    Tompkins MB; Ogilvie GK; Gast AM; Franklin R; Weigel R; Tompkins WA
    J Biol Response Mod; 1989 Feb; 8(1):86-96. PubMed ID: 2537886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement.
    Grant CK; DeBoer DJ; Essex M; Worley MB; Higgins J
    J Immunol; 1977 Aug; 119(2):401-6. PubMed ID: 196021
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A; Grófová M
    Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of feline retroviral suppression by indomethacin.
    Lewis MG; Fertel RH; Olsen RG
    Leuk Res; 1985; 9(12):1451-6. PubMed ID: 3001436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens.
    Lee TH; Essex M; de Noronha F; Azocar J
    Cancer Res; 1982 Oct; 42(10):3995-9. PubMed ID: 6286102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of suppression of lymphocyte proliferation by Concanavalin A-activated mononuclear cells.
    Lomnitzer R; Rabson AR
    Immunology; 1981 Jul; 43(3):475-81. PubMed ID: 6454655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of virus-induced immune suppression.
    Strayer DS; Leibowitz JL
    J Immunol; 1986 Apr; 136(7):2649-53. PubMed ID: 3005416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease.
    Grant CK; Pickard DK; Ramaika C; Madewell BR; Essex M
    Cancer Res; 1979 Jan; 39(1):75-81. PubMed ID: 216484
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of feline leukemia virus-infected and normal cat T-cell lines in interleukin 2-conditioned medium.
    Grant CK; Ernisse BJ; Pontefract R
    Cancer Res; 1984 Feb; 44(2):498-502. PubMed ID: 6318972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.